Stock listing

Cboe Canada:KNE Kane Biotech Inc. Stock

Canadian listing (Cboe Canada) of Kane Biotech Inc. · home listing TSXV:KNE

Follow Kane Biotech Inc. into a list and get an email when it puts out news.

Home listing price · TSXV:KNE

$0.03 CAD 0.00 (0.0%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:KNE

Past 3 months 0.0% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$0.025 – $0.03 CADOct 19, 2026
Volume
23,000 sharesOct 19, 2026
Market cap
$6.15M CADAt the close on Oct 19, 2026 · price × 205.1M shares outstanding
Kane Biotech Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:KNE · Home$0.03 CAD0.00 (0.0%)23,000$0.03$0.03$0.025$0.03Close on Oct 19, 2026
OTC:KNBIF$0.017 USD-0.003 (-16.4%)28,000$0.017$0.017$0.017$0.021Close on Oct 16, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · TSXV:KNE · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.030.000.0%$0.03$0.03$0.02523,000
$0.03+0.005+20.0%$0.025$0.03$0.02544,000
$0.0250.000.0%$0.025$0.025$0.02569,280
$0.025-0.005-16.7%$0.025$0.025$0.02550,800
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.033,300
$0.030.000.0%$0.03$0.03$0.032,500
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.035,100
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.034,000
$0.030.000.0%$0.03$0.03$0.031,000
$0.030.000.0%$0.03$0.03$0.03109,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.03100,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.035,000
$0.030.000.0%$0.03$0.03$0.0313,600
$0.030.000.0%$0.03$0.03$0.037,100
$0.030.000.0%$0.03$0.03$0.03179,000
$0.030.000.0%$0.03$0.03$0.0312,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.031,800
$0.03+0.01+50.0%$0.03$0.03$0.0344,900
$0.02-0.005-20.0%$0.03$0.03$0.02132,200
$0.025-0.005-16.7%$0.025$0.025$0.025133,000
$0.030.000.0%$0.03$0.03$0.0335,300
$0.030.000.0%$0.03$0.03$0.0316,100
$0.030.000.0%$0.03$0.03$0.03151,000
$0.030.000.0%$0.03$0.03$0.037,000
$0.030.000.0%$0.03$0.03$0.03102,100
$0.030.000.0%$0.03$0.03$0.032,000
$0.030.000.0%$0.03$0.03$0.0337,500
$0.030.000.0%$0.03$0.03$0.0327,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.0317,200
$0.030.000.0%$0.03$0.03$0.037,600
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.0318,100
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.03747,900
$0.03+0.01+50.0%$0.03$0.03$0.03796,700
$0.020.000.0%$0.02$0.02$0.02414,000
$0.02-0.01-33.3%$0.03$0.03$0.021,391,200
$0.030.000.0%$0.03$0.03$0.032,000
$0.030.000.0%$0.03$0.03$0.03157,000
$0.030.000.0%$0.03$0.03$0.0341,000
$0.030.000.0%$0.03$0.03$0.039,000
$0.030.000.0%$0.03$0.03$0.031,000
$0.030.000.0%$0.03$0.03$0.030
$0.030.000.0%$0.03$0.03$0.033,000
$0.030.000.0%$0.03$0.03$0.03144,500
$0.030.000.0%$0.03$0.03$0.0317,000
$0.03+0.005+20.0%$0.03$0.03$0.034,000
$0.025-0.005-16.7%$0.025$0.025$0.02545,700
$0.030.000.0%$0.03$0.03$0.031,500
$0.030.000.0%$0.03$0.03$0.0336,000
$0.030.000.0%$0.03$0.03$0.03108,000
Ticker
Cboe Canada:KNE
Asset type
Stock
Exchange
Cboe Canada
Currency
CAD

What changed lately

Calls

Replays

  • Kane Biotech (TSXV:KNE) Q3 2024 Earnings Call

    Tue, Dec 03, 2024 · 4:30 PM ET

    Watch Transcript
  • Kane Biotech (TSXV:KNE) Q2 2024 Earnings Call

    Thu, Aug 29, 2024 · 4:30 PM ET

    Watch Transcript
  • Kane Biotech (TSXV:KNE) Q1 2024 Earnings Call

    Wed, May 22, 2024 · 5:00 PM ET

    Watch Transcript

Latest news

All Kane Biotech Inc. news

Decks

Kane Biotech Inc. on 6ix

News releases
29 in the last 12 months · 48 in all · newest Oct 20, 2026 · oldest 2011
Calls
15 calls with a replay · 15 with a transcript · latest Dec 3, 2024
Decks
4 decks · latest May 2026

Where Kane Biotech Inc. is listed

ListingExchangeCountryCurrency
TSXV:KNE · Home listingTSXVCanadaCAD
OTC:KNBIFOTCUnited StatesUSD
Cboe Canada:KNE · This pageCboe CanadaCanadaCAD

Log in to ask 6ix AI your own questions about Kane Biotech Inc.